Skip to main content
. 2004 Mar;10(3):389–394. doi: 10.3201/eid1003.030702

Table. Eligible cases lost to enrollment in a hypothetical trial of ribavirin during the first outbreak of SARS in Toronto.

Date from outbreak recognition to date of enrollment of first patient (days) Number of cases lost to enrollment (%)
March 13–16 (3)
6/249 (2)
March 13–20 (7)
37/249 (15)
March 13–23 (10)
62/249 (25)
March 13–28 (15)a
114/249 (46)
March 13–31 (18)b 149/249 (60)

aApproval from first local ethics review board
bApproval from Health Canada